ea0099oc12.3 | Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition | Part II | ECE2024
Baumgartner Clemens
, Metz Matthaeus
, Pfleger Lorenz
, Tosin Anna
, Beghini Marianna
, Beiglboeck Hannes
, Fellinger Paul
, Schnait Franziska
, Vila Greisa
, Luger Anton
, Kautzky-Willer Alexandra
, Freudenthaler Angelika
, Baumgartner-Parzer Sabina
, Stangl Herbert
, Krssak Martin
, Scherer Thomas
, Krebs Michael
, Wolf Peter
Overview: Non-alcoholic fatty liver disease (NAFLD) is defined as a chronic increase in intrahepatic lipids (IHL). A surplus of IHL can be compensated through increased lipid export via very-low density lipoprotein (VLDL) particles. Growth hormone (GH) is known to reduce visceral and ectopic fat. However, the main pathways responsible for the in-vivo decrease of IHL under the influence of GH are yet to be determined.Methods: We assessed hepatic lipid met...